Tracks information on drugs on worldwide basis by Dr Anthony Melvin Crasto, helping millions with websites, 9 million hits on google, 2.5 lakh connections worldwide, P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.
Swedish pharmaceutical company Moberg Pharma has completed enrolling patients in the ongoing Phase II trial of MOB-015 for the treatment of nail fungus (onychomycosis).
No comments:
Post a Comment